title: Computational modeling of tuberculous meningitis reveals an important role for tumor necrosis factor-α.
abstract: Tuberculosis is a global health issue with annually about 1.5 million deaths and 2 billion infected people worldwide. Extra-pulmonary tuberculosis comprises 13% of all cases of which tuberculous meningitis is the most severe. It has a high mortality and is often diagnosed once irreversible neurological damage has already occurred. Development of diagnostic and treatment strategies requires a thorough understanding of the pathogenesis of tuberculous meningitis. This disease is characterized by the formation of a cerebral granuloma, which is a collection of immune cells that attempt to immunologically restrain, and physically contain bacteria. The cytokine tumor necrosis factor-α is known for its important role in granuloma formation. Because traditional experimental animal studies exploring tuberculous meningitis are difficult and expensive, another approach is needed to begin to address this important and significant disease outcome. Here, we present an in silico model capturing the unique immunological environment of the brain that allows us to study the key mechanisms driving granuloma formation in time. Uncertainty and sensitivity analysis reveals a dose-dependent effect of tumor necrosis factor-α on bacterial load and immune cell numbers thereby influencing the onset of tuberculous meningitis. Insufficient levels result in bacterial overgrowth, whereas high levels lead to uncontrolled inflammation being detrimental to the host. These findings have important implications for the development of immuno-modulating treatment strategies for tuberculous meningitis.
authors.affiliation: Department of Pediatric Infectious diseases and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: El-Kebir
authors.forename: M
authors.initials: M
authors.lastname: van der Kuip
authors.forename: A M
authors.initials: AM
authors.lastname: van Furth
authors.forename: D E
authors.initials: DE
authors.lastname: Kirschner
mesh_terms: D058491:Bacterial Load; D003198:Computer Simulation; D006099:Granuloma / Q000276:immunology*; D006801:Humans; D018448:Models, Immunological; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D014390:Tuberculosis, Meningeal / Q000175:diagnosis / Q000276:immunology* / Q000401:mortality; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D014409:Tumor Necrosis Factor-alpha
references.citation: Int J Tuberc Lung Dis. 2006 May;10(5):588-90
references.pmid: 16704045
references.citation: Cell. 2012 Feb 3;148(3):434-46
references.pmid: 22304914
references.citation: J Occup Environ Hyg. 2005 Mar;2(3):143-54
references.pmid: 15764538
references.citation: J Immunol. 2005 Feb 15;174(4):2288-96
references.pmid: 15699164
references.citation: Proc Natl Acad Sci U S A. 2002 May 14;99 Suppl 3:7280-7
references.pmid: 12011407
references.citation: Eur Respir J. 2008 Jan;31(1):99-105
references.pmid: 17804450
references.citation: J Theor Biol. 2008 May 7;252(1):24-38
references.pmid: 18321531
references.citation: Curr Mol Med. 2009 Mar;9(2):94-9
references.pmid: 19275620
references.citation: Immunol Rev. 2006 Oct;213:48-65
references.pmid: 16972896
references.citation: Trends Immunol. 2007 Jan;28(1):12-8
references.pmid: 17129764
references.citation: Microcirculation. 2006 Jan;13(1):1-18
references.pmid: 16393942
references.citation: J Neuroimmune Pharmacol. 2009 Dec;4(4):369-70
references.pmid: 19763835
references.citation: Clin Microbiol Rev. 2004 Oct;17(4):942-64, table of contents
references.pmid: 15489356
references.citation: Pediatr Infect Dis J. 2007 May;26(5):428-31
references.pmid: 17468654
references.citation: Paediatr Respir Rev. 2001 Jun;2(2):113-9
references.pmid: 12531057
references.citation: N Engl J Med. 2004 Oct 21;351(17):1741-51
references.pmid: 15496623
references.citation: Immunity. 1995 Jun;2(6):561-72
references.pmid: 7540941
references.citation: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002244
references.pmid: 18254003
references.citation: J Neurosci Res. 2007 Aug 15;85(11):2374-84
references.pmid: 17551981
references.citation: Infect Immun. 1998 Feb;66(2):794-9
references.pmid: 9453643
references.citation: J Immunol. 2011 Mar 15;186(6):3472-83
references.pmid: 21321109
references.citation: J Immunol. 2012 Apr 1;188(7):3169-78
references.pmid: 22379032
references.citation: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5657-62
references.pmid: 10318940
references.citation: J Infect Dis. 1998 Jun;177(6):1563-72
references.pmid: 9607834
references.citation: Pediatrics. 2009;123(1):e1-8
references.pmid: 19367678
references.citation: Immunity. 2008 Aug 15;29(2):283-94
references.pmid: 18691913
references.citation: J Infect Dis. 1995 Oct;172(4):1137-40
references.pmid: 7561198
references.citation: J Infect Dis. 2005 Dec 15;192(12):2054-8
references.pmid: 16288367
references.citation: Am Fam Physician. 2005 Nov 1;72(9):1761-8
references.pmid: 16300038
references.citation: Nat Rev Immunol. 2012 Apr 20;12(5):352-66
references.pmid: 22517424
references.citation: Tuberculosis (Edinb). 2010 Nov;90(6):361-6
references.pmid: 20829117
references.citation: Infect Immun. 2003 Oct;71(10):5831-44
references.pmid: 14500505
references.citation: J Theor Biol. 2008 Sep 7;254(1):178-96
references.pmid: 18572196
references.citation: J Immunol. 2011 Nov 1;187(9):4744-53
references.pmid: 21957139
references.citation: J Infect Dis. 2006 May 1;193(9):1287-95
references.pmid: 16586367
references.citation: J Immunol. 2005 Jul 1;175(1):579-90
references.pmid: 15972695
references.citation: Infect Immun. 2009 Oct;77(10):4631-42
references.pmid: 19620341
references.citation: Epidemiol Infect. 2013 Mar;141(3):459-62
references.pmid: 22647556
references.citation: N Engl J Med. 2001 Oct 11;345(15):1098-104
references.pmid: 11596589
references.citation: Nat Immunol. 2006 Mar;7(3):247-55
references.pmid: 16444260
references.citation: J Immunol. 2009 Mar 15;182(6):3706-17
references.pmid: 19265149
references.citation: J Immunol. 2001 Oct 15;167(8):4644-50
references.pmid: 11591794
references.citation: PLoS One. 2011;6(12):e27821
references.pmid: 22174748
references.citation: Nat Rev Microbiol. 2009 Dec;7(12):845-55
references.pmid: 19855401
references.citation: PLoS One. 2009 Sep 30;4(9):e7277
references.pmid: 19789647
references.citation: Cell. 2010 Mar 5;140(5):717-30
references.pmid: 20211140
references.citation: J Infect Dis. 2006 Oct 15;194(8):1127-1134
references.pmid: 16991088
references.citation: J Theor Biol. 2011 Jul 7;280(1):50-62
references.pmid: 21443879
references.citation: J Child Neurol. 2011 Aug;26(8):956-62
references.pmid: 21628697
references.citation: Neuroscience. 1992;48(2):405-15
references.pmid: 1603325
references.citation: J Child Neurol. 2004 Apr;19(4):250-7
references.pmid: 15163089
references.citation: J Exp Med. 1973 Dec 1;138(6):1314-30
references.pmid: 4762549
references.citation: J Clin Invest. 2004 Nov;114(10):1372-8
references.pmid: 15545984
references.citation: Glia. 2001 Nov;36(2):165-79
references.pmid: 11596125
references.citation: Lancet. 1999 Feb 6;353(9151):444-9
references.pmid: 9989714
references.citation: Clin Microbiol Rev. 2008 Apr;21(2):243-61, table of contents
references.pmid: 18400795